Stimcell Energetics (STME) Asset Utilization Ratio (2017 - 2024)
Stimcell Energetics' (STME) quarterly Asset Utilization Ratio came in at 0.0 in Q1 2024, down 99.02% year-on-year from 0.14 in Q1 2023, and down 79.67% quarter-over-quarter from 0.01 in Q4 2023.
Stimcell Energetics (STME) Asset Utilization Ratio (2017 - 2024) Analysis & Trends
Stimcell Energetics' Asset Utilization Ratio history runs 8 years deep, the most recent figure standing at 0.0 for Q1 2024.
- On a quarterly basis, Asset Utilization Ratio fell 99.02% year-over-year to 0.0 in Q1 2024; TTM through Feb 2024 was 0.0, a 99.02% decrease from a year earlier, with the FY2023 full-year figure at 0.04, down 25.12% from the prior year.
- Asset Utilization Ratio slipped to 0.0 in Q1 2024 per STME's latest filing, from 0.01 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.83 in Q1 2021 and bottomed at 0.0 in Q1 2024.
- The 5-year median for Asset Utilization Ratio is 0.09 (2022), against an average of 0.19.
- Across the five-year window, Asset Utilization Ratio soared 686.77% in 2021 and plunged 99.02% in 2024, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.49 in 2020, then slumped by 85.19% to 0.07 in 2021, then jumped by 54.83% to 0.11 in 2022, then tumbled by 93.78% to 0.01 in 2023, then slumped by 79.67% to 0.0 in 2024.
- Per Business Quant, the three latest STME Asset Utilization Ratio figures stand at 0.0 (Q1 2024), 0.01 (Q4 2023), and 0.01 (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.74 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.65 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.57 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 29, 2024 | 0.00 |
| Nov 30, 2023 | 0.01 |
| Aug 31, 2023 | 0.01 |
| May 31, 2023 | 0.03 |
| Feb 28, 2023 | 0.14 |
| Nov 30, 2022 | 0.11 |
| Aug 31, 2022 | 0.11 |
| May 31, 2022 | 0.09 |
| Feb 28, 2022 | 0.07 |
| Nov 30, 2021 | 0.07 |
| Aug 31, 2021 | 0.08 |
| May 31, 2021 | 0.09 |
| Feb 28, 2021 | 0.83 |
| Nov 30, 2020 | 0.49 |
| Aug 31, 2020 | 0.45 |
| May 31, 2020 | 0.57 |
| Feb 29, 2020 | 0.10 |
| Nov 30, 2019 | 0.07 |
| Aug 31, 2019 | 0.06 |
| Nov 30, 2018 | 0.01 |